Hospital Quiron Barcelona
| トルコ | オーストリア | スペイン | |
| 対症療法 | から $300 | から $700 | から $800 |
バティスタ医師はバルセロナにおけるレーザー手術の先駆者であり、泌尿器科領域で1,100件以上の治療を実施しています。センター・メディコ・テクノン（Centro Médico Teknon）にてUroクリニカ部門を設立し、現在も統括しています。
Dr. Josep Torremade Barreda is the Head of Andrology at Teknon Medical Center in Barcelona. He specializes in male reproductive medicine, sexology, and complex urological surgery. Dr. Torremade Barreda has served as the Editor of the International Journal of Andrology since 2016. He completed specialized training at the Memorial Sloan Kettering Cancer Center in New York.
Dr. Navarro Vilches leads the Urology Unit at Quirónsalud Marbella Hospital. He specializes in male reproductive health and lower urinary tract surgery. Dr. Vilches completed a study stay at the Memorial Sloan-Kettering Cancer Center in New York. He is a co-founder of the Urologic Surgery Institute of Malaga.
Dr. Antonio Allona is Director of the Urology Unit at Hospital Ruber Internacional (Madrid) since 1993. He has more than 40 years of experience in prostate cancer, reconstructive urology, and andrology. He is known for complex urological surgery and advanced cancer treatments.
Career: Head of Urology and Andrology at Ruber Internacional. Senior Urologist at Hospital Universitario Ramón y Cajal (1981–2010). Specialist at Centro Médico Teknon.
Credentials: MD, University of Granada (1977), Special Degree Award. PhD, University of Alcalá de Henares, cum laude (thesis on detubularised ileal reservoir). FEBU Fellow (1992). Foreign Medical Examination certification (1980).
Contributions: Member of the National Commission of Urology (1986–2004). General Secretary of the AEU for eight years. Held board roles in international societies. Contributed to advances in bladder reconstruction and functional urology. Member of the AEU, Spanish Association of Andrology, EAU, AUA, SIU, and the American Confederation of Urology.
Top hospitals in Spain for polycystic kidney disease (PKD) treatment include JCI-accredited facilities like Centro Médico Teknon and Hospital Quiron Barcelona. These centers provide expert urological consultations. They manage symptoms and complications of PKD using robotized surgeries and advanced imaging like MRI.
Bookimed Expert Insight: Choosing a large hospital network like HM Hospitales or Quirónsalud provides a significant safety net. These networks, such as Hospital HM Nou Delfos or Quironsalud Madrid, serve over 400,000 patients yearly. This high volume ensures that specialists have extensive experience with rare PKD complications. Patients also gain access to clinical trials for neurodegenerative research through these larger institutions.
Patient Consensus: Patients note it is important to choose hospitals that offer personalized care and international services. They appreciate clinics that provide airport transfers and nearby hotel accommodations to make the treatment process smoother.
Expert nephrologists in Spain treat polycystic kidney disease using advanced molecular diagnostics and robotic surgery. Dr. Roser Torra and Dr. Jorge Moises Sandrus are leading specialists in Barcelona. Patients access multidisciplinary care at JCI-accredited centers like Centro Medico Teknon and Hospital Quiron Barcelona.
Bookimed Expert Insight: Barcelona has become a primary hub for hereditary kidney care due to massive patient volumes. Centro Medico Teknon alone manages 10,000 patients annually. This high concentration of cases allows specialists to refine diagnostic protocols for rare genetic variations. Doctors here often coordinate between 50 different departments to manage multi-organ PKD symptoms.
Patient Consensus: Patients note the importance of choosing centers with international departments for smooth coordination. Many highlight that personalized treatment plans in Barcelona often combine genetic counseling with long-term monitoring.
Tolvaptan is available in Spain as a standard treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD). The drug is used in major hospitals to slow cyst growth. Eligible adults must show rapid progression and satisfy specific kidney function criteria. European Medicines Agency protocols require local monthly liver monitoring.
Bookimed Expert Insight: Spain ranks third globally on Bookimed for medical travel, reflecting a highly regulated healthcare system where innovative drugs like Tolvaptan are integrated into clinical networks. While large public centers manage many cases, private facilities like those in the HM Hospitales network offer streamlined access to specialists like Dr. Javier Romero Otero. This ensures that international patients can receive advanced symptomatic treatment in JCI-accredited environments that handle over 400,000 patients annually.
Patient Consensus: Patients note that while the national health system covers the drug, regional approvals can take around 3 months to finalize. Those using the medication emphasize that initial side effects like extreme thirst usually become more manageable after several weeks.
Spanish clinics treat polycystic kidney disease through symptomatic management and advanced surgical interventions. Specialists focus on slowing cyst growth with targeted drug therapies like Tolvaptan. High-volume centers in Barcelona and Madrid integrate minimally invasive urology and robotic systems to manage complications and preserve renal function effectively.
Bookimed Expert Insight: Spanish healthcare excellence is driven by massive patient volumes and specialized expertise. Hospital HM Nou Delfos and Centro Médico Teknon each treat over 10,000 patients annually. Doctors like Dr. Jose Emilio Batista Miranda bring over 35 years of experience to complex cases. This high volume across JCI-accredited facilities ensures refined clinical protocols and reliable outcomes for chronic renal management.
Patient Consensus: Patients value the speed of donor matching in Spain compared to other countries. Many note that conservative lifestyle changes and blood pressure control are prioritized before considering more invasive surgical options.
Kidney transplantation is available in Spain for patients with polycystic kidney disease. Spain maintains a high transplant rate and leads the world in organ donation. Specialists at major centres manage end-stage renal disease through living and deceased donor transplant programs.
Bookimed Expert Insight: Spain ranks third globally for medical requests. However, transplant access for international patients often requires a living donor. Our data shows that top urologists like Dr Antonio Allona have over 40 years of experience. They focus on complex reconstruction. This is vital for PKD patients with enlarged kidneys.
Patient Consensus: Patients note that eligibility depends heavily on local legislation and donor availability. It is important to organise follow-up care in Australia. You should also confirm medical paperwork early due to complex legal requirements in Spain.
Spain treats polycystic kidney disease through medication, blood pressure management, and specialist urological care. Major centres in Madrid and Barcelona follow European Medicines Agency guidelines. They use tolvaptan to slow cyst growth. Severe cases may require dialysis or transplantation at JCI-accredited facilities.
Bookimed Expert Insight: Spanish clinics like Hospital Universitario HM Sanchinarro have extensive experience with international patients. This includes those from Commonwealth countries. Familiarity with Australian-style medical expectations ensures smoother communication during complex renal treatments. Some clinics also provide dedicated medical coordinators to assist with long-term kidney monitoring.
Patient Consensus: Patients note that Spanish specialists focus heavily on early blood pressure control and regular imaging. They also suggest discussing transplant eligibility early to understand the referral pathway in Spain.
Active clinical trials for polycystic kidney disease (PKD) exist in Spain. These studies investigate drugs like dapagliflozin to slow kidney decline. Major centres like Quironsalud Madrid offer trial participation for eligible patients. Some research focuses on gene therapies using CRISPR technology.
Bookimed Expert Insight: Spain ranks third globally for medical requests. It serves nearly 1,500 patients annually through 83 clinics. While many focus on surgery, Quironsalud Madrid allows patients to participate in clinical trials for free. This provides access to emerging PKD therapies that are not yet standard in Australia.
Spanish hospitals provide genetic counselling for polycystic kidney disease (PKD) through specialised nephrology units and molecular research departments. Centres like Centro Médico Teknon and Hospital Quiron Barcelona offer these services. Expert nephrologists manage inheritance discussions. However, Spain does not recognise genetic counselling as a separate medical speciality.
Bookimed Expert Insight: Spain ranks third globally on Bookimed for patient requests. This is largely due to its high-volume centres. Hospitals like HM Nou Delfos and Hospital Ruber Internacional serve over 400,000 and 25,000 patients annually. This scale means doctors see rare genetic variations more frequently than in smaller clinics.
Patient Consensus: Patients note that availability varies across Spain. Verifying in-house genetics clinics is essential. Many recommend confirming if telehealth is available for follow-up results after returning to Australia.
Specialists in Spain diagnose polycystic kidney disease through imaging, clinical assessment, and genetic studies. Spanish nephrologists use ultrasound as the first-line check to detect kidney cysts. MRI and CT scans then help calculate kidney volume to track disease progression.
Bookimed Expert Insight: Spanish centres such as Hospital Ruber Internacional and Hospital HM Nou Delfos offer 3-Tesla MRI and EOS imaging. These technologies provide high-resolution data that traditional scans miss. Patients benefit from precise total kidney volume (TKV) measurements. This metric is the gold standard for predicting future kidney function decline.
Patient Consensus: Patients value how Spanish specialists combine imaging with thorough family history reviews. They often mention the efficiency of accessing MRI and genetic testing in centres like Barcelona.
Spanish clinics manage polycystic kidney disease pain through a stepwise approach. Doctors use non-opioid medications initially. Persistent pain may require cyst aspiration, where specialists drain fluid. Surgical options include laparoscopic cyst decortication. This removes cyst tops to reduce kidney pressure. Specialist urology consults cost A$100 to A$300.
Bookimed Expert Insight: Spain ranks third globally for patient requests on our platform. This high demand leads to centres like Hospital Universitario HM Sanchinarro specialising in adult urology. Australian patients benefit from doctors with international training, such as Dr Navarro Vilches. He studied at Memorial Sloan-Kettering. This expertise means specialists manage complex renal pain with recognised protocols.
Polycystic kidney disease cannot be cured in Spain as it is a genetic condition. Spanish specialists focus on managing symptoms and slowing progression using medication. Leading centres such as Centro Médico Teknon and Hospital Universitario HM Sanchinarro provide kidney transplantation for severe cases.
Bookimed Expert Insight: Spain ranks third globally for patient requests in our network. This is largely due to its high concentration of JCI-accredited facilities. While a cure does not exist, centres like Hospital Ruber Internacional use the Da Vinci Xi robotic system. This technology allows for minimally invasive approaches when treating urological complications.
Patient Consensus: Patients note that Spain offers a high standard of specialist care. They emphasise that treatment aims to manage life with the condition. Many recommend verifying if a procedure is for symptom control or transplant evaluation before travelling.